Literature DB >> 10510274

Inhibition of antioxidants and hyperthermia enhance bleomycin-induced cytotoxicity and lipid peroxidation in Chinese hamster ovary cells.

A Khadir1, J Verreault, D A Averill.   

Abstract

Regional hyperthermia has potential for human cancer treatment, particularly in combination with systemic chemotherapy or radiotherapy. Heat enhances the cytotoxic effect of certain anticancer agents such as bleomycin, but the mechanisms involved in cell killing are currently unknown. Bleomycin generates reactive oxygen species. It is likely that hyperthermia itself also increases oxidative stress in cells. We evaluate whether oxidative stress has a role in the mechanism of cell death caused by bleomycin and heat in Chinese hamster ovary cells. Heat (41 to 44 degrees C) increased cytotoxicity of bleomycin, evaluated by clonogenic cell survival. Decreased levels of cellular antioxidants should create an imbalance between prooxidant and antioxidant systems, thus enhancing cytotoxic responses to heat and to oxidant-generating drugs. We determine the involvement of four major cellular antioxidant defenses, superoxide dismutase (SOD), the glutathione redox cycle (GSH cycle), catalase, and glutathione S-transferase (GST), in cellular sensitivity to bleomycin, alone or combined with hyperthermia. These cellular defenses were inhibited by diethyldithiocarbamate, l-buthionine sulfoximine, aminotriazole, and ethacrynic acid, respectively. We show that levels of antioxidants (SOD, GSH cycle, and GST) affect cellular cytotoxic responses to bleomycin, at normal and elevated temperatures (41 to 44 degrees C), suggesting the involvement of oxidative stress. Bleomycin and iron caused oxidative damage to membrane lipids in intact cells, at 37 and 43 degrees C. Lipid peroxidation was evaluated by fluorescence detection of thiobarbituric acid-reactive products. There was an increase in damage to membrane lipids when the antioxidant defenses, SOD and catalase, were inhibited. The differing effects of antioxidant inhibitors on bleomycin-induced cytotoxicity and membrane lipid damage suggest that different mechanisms are involved in these two processes. However, free radicals appear to be involved in both cases. The marked sensitization of cells by diethyldithiocarbamate, to both bleomycin-induced cytotoxicity and lipid peroxidation, suggests that superoxide could be involved in both of these processes. Copyright 1999 Academic Press.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10510274     DOI: 10.1006/abbi.1999.1393

Source DB:  PubMed          Journal:  Arch Biochem Biophys        ISSN: 0003-9861            Impact factor:   4.013


  5 in total

1.  Use of arsenic trioxide as an antivascular and thermosensitizing agent in solid tumors.

Authors:  R J Griffin; S H Lee; K L Rood; M J Stewart; J C Lyons; Y S Lew; H Park; C W Song
Journal:  Neoplasia       Date:  2000 Nov-Dec       Impact factor: 5.715

2.  Efficient methodology for the synthesis of 3-amino-1,2,4-triazoles.

Authors:  Romain Noël; Xinyi Song; Rong Jiang; Michael J Chalmers; Patrick R Griffin; Theodore M Kamenecka
Journal:  J Org Chem       Date:  2009-10-02       Impact factor: 4.354

3.  Toxic-dose warfarin-induced apoptosis and its enhancement by gamma ionizing radiation in leukemia K562 and HL-60 cells is not mediated by induction of oxidative stress.

Authors:  Ilhan Onaran; Sevide Sencan; Halil Demirtaş; Birsen Aydemir; Turgut Ulutin; Murat Okutan
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  2008-06-21       Impact factor: 3.000

4.  Mechanisms of rapid sensory hair-cell death following co-administration of gentamicin and ethacrynic acid.

Authors:  Dalian Ding; Haiyan Jiang; Richard J Salvi
Journal:  Hear Res       Date:  2009-08-26       Impact factor: 3.208

5.  Aldo-Keto Reductase 1B10 and Its Role in Proliferation Capacity of Drug-Resistant Cancers.

Authors:  Toshiyuki Matsunaga; Yasuhiro Wada; Satoshi Endo; Midori Soda; Ossama El-Kabbani; Akira Hara
Journal:  Front Pharmacol       Date:  2012-01-31       Impact factor: 5.810

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.